HCA Forecast, price target & analysts
HCA Target price 2025 - Analyst rating & recommendation
HCA Classifications & Recommendation:
HCA Price Target
| Target Price | $397.80 |
| Price | $379.30 |
| Potential |
4.88%
register free of charge
|
| Number of Estimates | 25 |
|
25 Analysts have issued a price target HCA 2026 .
The average HCA target price is $397.80.
This is
4.88%
register free of charge
$466.20
22.91%
register free of charge
$319.62
15.74%
register free of charge
|
|
| A rating was issued by 30 analysts: 19 Analysts recommend HCA to buy, 10 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the HCA stock has an average upside potential 2026 of
4.88%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 70.60 | 75.46 |
| 8.67% | 6.88% | |
| EBITDA Margin | 19.63% | 19.84% |
| 0.38% | 1.07% | |
| Net Margin | 8.16% | 8.24% |
| 1.11% | 1.00% |
26 Analysts have issued a sales forecast HCA 2025 . The average HCA sales estimate is
This results in the following potential growth metrics:
25 Analysts have issued an HCA EBITDA forecast 2025. The average HCA EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
27 HCA Analysts have issued a net profit forecast 2025. The average HCA net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 22.00 | 25.60 |
| 16.03% | 16.36% | |
| P/E | 14.82 | |
| EV/Sales | 1.79 |
27 Analysts have issued a HCA forecast for earnings per share. The average HCA EPS is
This results in the following potential growth metrics and future valuations:
Current HCA Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RBC Capital |
Locked
➜
Locked
|
Locked | Jun 23 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jun 09 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Jun 02 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | May 29 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Apr 15 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jun 23 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jun 09 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jun 02 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
May 29 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Apr 28 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Apr 15 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Apr 09 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
